EU Pharma Ups Share Buybacks In 2012
This article was originally published in The Pink Sheet Daily
Executive Summary
Share buybacks are controversial in the biopharma industry, but European pharma companies, facing tough operating environments and pressures on near-term financials, are planning to invest in them in 2012 more than in recent years.